Iñaki Troconiz

34PUBLICATIONS
89CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples medicine and treatmentsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 14, 2026
Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix.

|Jun 10, 2026
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

|Jan 29, 2026
A QSP Model of Valproic Acid Toxicity in Pediatric and Adult Populations: Implications for Formulation Selection and L-Carnitine Supplementation.

Alejandra Schiavo, Cecilia Maldonado, Marta Vázquez

|Dec 31, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.

Javier Varela-González-Aller, Mario Andrés Sánchez-Salinas, Iñaki Troconiz

|Nov 29, 2025
Design Optimization for Developing Population Pharmacokinetic Models in Critically Ill Children: Application to Teicoplanin, Piperacillin and Meropenem.

Gastón García-Orueta, Laura Butragueño-Laiseca, María José Santiago

|Nov 18, 2025
Leveraging in vitro Tumor Cell Killing and Cytokine Release to Predict Cytokine Release Syndrome Associated with CD3 T-cell Bispecifics in Oncology: a Retrospective Analysis.

Apolline Lefèvre, Zinnia P Parra-Guillen, Iñaki F Trocóniz

Pageof 6

Frequent Collaborators

9 joint publications

Zinnia Parra-Guillen

4 joint publications

Aymara Sancho-Araiz

3 joint publications

Gloria Iacoboni

3 joint publications

Mario Andrés Sánchez-Salinas